KNSA Kiniksa Pharmaceuticals Ltd

$33.75

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Kiniksa Pharmaceuticals Ltd

No Company Description Available

Website: N/A

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1730430
Address
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BM
Valuation
Market Cap
$1.47B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
3.35
Performance
EPS
$-0.60
Dividend Yield
—
Profit Margin
-10.20%
ROE
-9.85%
Technicals
50D MA
$21.04
200D MA
$22.51
52W High
$28.15
52W Low
$16.87
Fundamentals
Shares Outstanding
42M
Target Price
$35.57
Beta
0.31

KNSA EPS Estimates vs Actual

● Estimated
● Actual

KNSA News & Sentiment

Aug 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc ( KNSA ) Could Rally 26.69%: Here's is How to Trade
The consensus price target hints at a 26.7% upside potential for Kiniksa Pharmaceuticals International, plc (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in ...
Aug 18, 2025 • Zacks Commentary BULLISH
Kiniksa Pharmaceuticals International, plc ( KNSA ) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Aug 13, 2025 • Zacks Commentary NEUTRAL
Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
TBPH posts better-than-expected second-quarter 2025 results, boosted by Yupelri sales and licensing gains.
Aug 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
5 Stocks With Recent Price Strength Amid Trade & Rate Cut Uncertainties
MOD, TPC, KNSA, LIF and ESEA are defying trade and rate-cut uncertainty with strong recent price momentum and earnings upgrades.
Aug 05, 2025 • Zacks Commentary BULLISH
Kiniksa Pharmaceuticals International, plc ( KNSA ) Is Up 21.46% in One Week: What You Should Know
Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aug 04, 2025 • Benzinga NEUTRAL
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Adial Pharmaceuticals ( NASDAQ:ADIL ) , ATA Creativity Global ( NASDAQ:AACG )
Shares of CommScope Holding Company, Inc. COMM rose sharply in pre-market trading. The Wall Street Journal reported Sunday that Amphenol is nearing a deal for CommScope's Broadband arm. CommScope Holding shares jumped 40.1% to $10.91 in the pre-market trading session.
Sentiment Snapshot

Average Sentiment Score:

0.203
50 articles with scored sentiment

Overall Sentiment:

Bullish

KNSA Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Pre market)
-0.25 Surprise
  • Reported EPS: $-0.12
  • Estimate: $0.13
  • Whisper: —
  • Surprise %: -192.3%
Oct 29, 2024
Sep 30, 2024 (Pre market)
-0.25 Surprise
  • Reported EPS: $-0.18
  • Estimate: $0.07
  • Whisper: —
  • Surprise %: -366.7%
Jul 23, 2024
Jun 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.06
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 14.3%
Apr 23, 2024
Mar 31, 2024 (Pre market)
-0.09 Surprise
  • Reported EPS: $-0.25
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -56.2%
Feb 28, 2024
Dec 31, 2023 (Pre market)
0.49 Surprise
  • Reported EPS: $0.35
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: 350.0%
Oct 31, 2023
Sep 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.20
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: -17.6%
Jul 25, 2023
Jun 30, 2023 (Pre market)
0.38 Surprise
  • Reported EPS: $0.21
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: 223.5%
May 02, 2023
Mar 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.18
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: 14.3%
Feb 28, 2023
Dec 31, 2022 (Pre market)
0.29 Surprise
  • Reported EPS: $0.06
  • Estimate: $-0.23
  • Whisper: —
  • Surprise %: 126.1%

Financials